Let's talk medical research

At Antidote, our mission is to connect patients with medical research opportunities. But one phrase we hear often from patients goes something like this: "Medical research is great, but it's not for me." Read more

There are conferences we attend to connect with clients. There are conferences we attend to build partnerships. At SCOPE, we are able to do both. The SCOPE Summit convenes the best, the brightest, and the most dedicated in the clinical trial operations space with one aim: to accelerate clinical research. This is why we go to SCOPE. Read more

Pulmonary hypertension (PH) is a type of high blood pressure in the lungs. A rare disease, PH is often misdiagnosed as asthma or COPD. Unfortunately, delays in diagnosis mean delays in treatment; sometimes, patients aren't diagnosed until they're in late stage disease – and by then, they have limited options. Read more

Despite decades of research, heart disease continues to be the leading cause of death for both men and women in the United States. It’s clear that tackling cardiovascular disease requires a new approach. That’s why today, researchers and heart health advocates are taking on heart disease, stroke, and other conditions from a variety of angles, from exploring precision medicine to driving clinical ... Read more

February 28 is Rare Disease Awareness Day. Despite the name "rare," taken together, rare diseases are actually very common – 350 million people live with a rare disease worldwide. Read more

If you're considering joining a clinical trial, chances are you're also familiar with the common reasons patients choose not to participate. Read more

At Antidote, our goal is to empower patients to connect with research and seek out the best treatments while learning more about their condition. Backpack Health, our newest partner, shares our mission and gives patients a way to lighten the load of living with a chronic disease in a simple, tangible way while connecting patients with research opportunities. Read more

During Q3 2018, Antidote Technologies and SCORR Marketing partnered on a survey to gain a deeper understanding of patient perceptions of clinical trials and what can motivate them to participate. Survey participants were recruited by eight of Antidote’s partners, including the American Kidney Fund, Allergy & Asthma Network, Healthline, JDRF, Lung Cancer Alliance, Lupus Research Alliance, Melanoma ... Read more

Once a year, we head to Orlando to collaborate with and learn from some of the best and brightest minds in clinical trial operations. That’s right: we’re attending the SCOPE Summit next week. Read more

Hemophilia is a rare genetic bleeding disorder, affecting around 20,000 people in the U.S. Most cases of hemophilia are inherited, but for about 30% of patients, it's caused by a spontaneous mutation in a gene associated with blood clotting. Read more